Establishing statewide standards governing the use of HIV post-exposure prophylaxis, permitting a pharmacist to initiate such medication to certain patients, providing civil liability protections to pharmacists who initiate prophylactic therapy to patients for post-exposure to human immunodeficiency virus.

HB 2100 allows pharmacists in Kansas to initiate HIV post-exposure prophylaxis (PEP) medication for patients who believe they've been exposed to HIV, directly affecting pharmacists and those at risk of HIV exposure. The bill requires the state board of pharmacy to create a statewide protocol mandating proper patient education on PEP use, safe administration, and follow-up care with a doctor, alongside accurate recordkeeping. Pharmacists acting in good faith under this protocol are protected from civil lawsuits, criminal charges, or professional discipline related to initiating PEP. The protocol must be established by January 1, 2026, to ensure timely access to HIV prevention medication outside of traditional medical settings.